Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

NCT07516886 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.

NCT NCT07516886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07516886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
Lead sponsor
Lithuanian University of Health Sciences
Phase
Observational
Overall status
Recruiting
Start date
January 22, 2024
Completion date
July 31, 2039
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (adenocarcinoma), prostate cancer (diagnosis), prostate cancer (post prostatectomy), prostate specific antigen, radical prostatectomy